Gene · 4939
Papers2,192
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,192
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Host-response transcriptional biomarkers accurately discriminate bacterial and viral infections of global relevance. | Sci Rep | 2023 | 38110534 | PubTator, text mining | PubMed |
| Crowdsourcing temporal transcriptomic coronavirus host infection data: Resources, guide, and novel insights. | Biol Methods Protoc | 2023 | 38107402 | PubTator, text mining | PubMed |
| Robust small molecule-aided cardiac reprogramming systems selective to cardiac fibroblasts. | iScience | 2023 | 38077137 | PubTator, text mining | PubMed |
| Analysis of gene expression profile for identification of novel gene signatures during dengue infection. | Infect Med (Beijing) | 2023 | 38076406 | PubTator, text mining | PubMed |
| Methyltransferase-like 3 (METTL3) inhibition potentiates anti-tumor immunity: a novel strategy for improving anti-PD1 therapy. | Signal Transduct Target Ther | 2023 | 38072988 | PubTator, text mining | PubMed |
| Identification of interferon-stimulated genes with modulated expression during hepatitis E virus infection in pig liver tissues and human HepaRG cells. | Front Immunol | 2023 | 38058490 | PubTator, text mining | PubMed |
| Integrated transcriptomics, proteomics, and functional analysis to characterize the tissue-specific small extracellular vesicle network of breast cancer. | MedComm (2020) | 2023 | 38053815 | PubTator, text mining | PubMed |
| Tumor-immune microenvironment and NRF2 associate with clinical efficacy of PD-1 blockade combined with chemotherapy in lung squamous cell carcinoma. | Cell Rep Med | 2023 | 38052215 | PubTator, text mining | PubMed |
| High-frequency home self-collection of capillary blood correlates IFI27 expression kinetics with SARS-CoV-2 viral clearance. | J Clin Invest | 2023 | 38038134 | PubTator, text mining | PubMed |
| Whole exome sequencing of patients with varicella-zoster virus and herpes simplex virus induced acute retinal necrosis reveals rare disease-associated genetic variants. | Front Mol Neurosci | 2023 | 38025266 | PubTator, text mining | PubMed |
| Single-cell transcriptomic atlas of distinct early immune responses induced by SARS-CoV-2 Proto or its variants in rhesus monkey. | MedComm (2020) | 2023 | 38020713 | PubTator, text mining | PubMed |
| Resurrection of 2'-5'-oligoadenylate synthetase 1 (OAS1) from the ancestor of modern horseshoe bats blocks SARS-CoV-2 replication. | PLoS Biol | 2023 | 38015855 | PubTator, text mining | PubMed |
| Single-Nuclei Multiome (ATAC + Gene Expression) Sequencing of a Primary Canine Osteosarcoma Elucidates Intra-Tumoral Heterogeneity and Characterizes the Tumor Microenvironment. | Int J Mol Sci | 2023 | 38003552 | PubTator, text mining | PubMed |
| Dpep Inhibits Cancer Cell Growth and Survival via Shared and Context-Dependent Transcriptome Perturbations. | Cancers (Basel) | 2023 | 38001578 | PubTator, text mining | PubMed |
| Allosteric SHP2 inhibition increases apoptotic dependency on BCL2 and synergizes with venetoclax in FLT3- and KIT-mutant AML. | Cell Rep Med | 2023 | 37992684 | PubTator, text mining | PubMed |
| The slan antigen identifies the prototypical non-classical CD16+-monocytes in human blood. | Front Immunol | 2023 | 37965335 | PubTator, text mining | PubMed |
| Reduction of IFN-I responses by plasmacytoid dendritic cells in a longitudinal trans men cohort. | iScience | 2023 | 37953956 | PubTator, text mining | PubMed |
| Identification and characterization of interferon-γ signaling-based personalized heterogeneity and therapeutic strategies in patients with pancreatic cancer. | Front Oncol | 2023 | 37941546 | PubTator, text mining | PubMed |
| Activation of Toll-like receptor 3 inhibits HIV infection of human iPSC-derived microglia. | J Med Virol | 2023 | 37933090 | PubTator, text mining | PubMed |
| Lipin-2 regulates the antiviral and anti-inflammatory responses to interferon. | EMBO Rep | 2023 | 37929625 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4939/papers?page=8